-
Calpain Inhibitor I, ALLN: Technical Guidance for Lab Resear
2026-05-09
Calpain Inhibitor I, ALLN enables precise inhibition of calpain and cathepsin proteases, making it a practical tool for apoptosis assays and ischemia-reperfusion injury models. It should not be used for diagnostic or therapeutic purposes, and requires careful handling due to its solubility and storage characteristics.
-
IWP-2: Wnt Production Inhibitor for Cancer and Cell Assays
2026-05-08
IWP-2, a high-potency Wnt production inhibitor from APExBIO, enables precise disruption of the Wnt/β-catenin pathway across cancer and developmental models. This article details robust workflows, advanced troubleshooting, and innovative cross-domain applications guided by recent morphological profiling breakthroughs.
-
Palonosetron Hydrochloride in CINV/RINV: Update and Clinical
2026-05-08
This literature-focused review elucidates the mechanistic and clinical advances of palonosetron hydrochloride as outlined in Fabi & Malaguti’s 2013 reference paper. The analysis highlights its high receptor affinity, prolonged antiemetic efficacy, and unique regulatory position for delayed chemotherapy- and radiotherapy-induced nausea and vomiting, with context from recent translational research.
-
Imatinib (STI571): Precision Kinase Inhibition in Signal Tra
2026-05-07
Explore the advanced scientific rationale for using Imatinib (STI571) in signal transduction research, with a focus on kinase selectivity, assay design, and cutting-edge mass spectrometry innovations. Gain unique insights that extend beyond established protocols and product pages.
-
CDC42-Driven Polarity Directs Intestinal Stem Cell Fate via
2026-05-07
Zhang et al. established that CDC42-dependent apical-basal polarity orchestrates the balance between intestinal stem cells and transit amplifying cells through a YAP-EGF-mTOR signaling cascade, independently of canonical Wnt signaling. This work advances the mechanistic understanding of epithelial homeostasis and provides a refined framework for studies on gastrointestinal regeneration and disease.
-
Gramine Triggers Ferroptosis in TNBC via the CUL3–MTDH Axis
2026-05-06
This study reveals that gramine, a natural indole alkaloid, suppresses triple-negative breast cancer (TNBC) by inducing ferroptosis through CUL3-mediated ubiquitination of MTDH. The findings delineate a novel therapeutic mechanism and pinpoint the CUL3–MTDH axis as a promising target for ferroptosis-based cancer interventions.
-
BIBP 3226 trifluoroacetate: Illuminating NPY/NPFF Axis for C
2026-05-06
Explore how BIBP 3226 trifluoroacetate empowers advanced research into neuropeptide Y and FF signaling in cardiac arrhythmia. This article uniquely translates mechanistic discoveries into actionable assay protocols for the NPY/NPFF system.
-
3-Deazaadenosine: Protocols for Methylation and Antiviral Re
2026-05-05
3-Deazaadenosine is a validated S-adenosylhomocysteine hydrolase inhibitor that powers both advanced epigenetic regulation studies and robust preclinical antiviral workflows. This article delivers actionable, evidence-backed protocols, troubleshooting insights, and a bridge to inflammation research, positioning APExBIO’s 3-Deazaadenosine as a reproducible, versatile tool for methylation and viral infection research.
-
Mitomycin C: Antitumor Antibiotic for DNA Replication Inhibi
2026-05-05
Mitomycin C is a potent antitumor antibiotic that directly inhibits DNA synthesis and replication, resulting in cytotoxicity and apoptosis in cancer models. It enables precise apoptosis signaling research and is widely used in translational oncology studies.
-
WM-8014: Precision KAT6A Inhibitor for Cancer Biology Resear
2026-05-04
WM-8014 empowers researchers to induce targeted oncogene-induced senescence and cell cycle arrest in vitro, without cytotoxicity. Its competitive, reversible inhibition of KAT6A/B makes it the gold standard for dissecting epigenetic dependencies in cancer biology and functional genomics workflows.
-
Alosetron as a Precision Tool for 5-HT3 Signaling in Intesti
2026-05-04
Unlock advanced insights into 5-HT3 receptor antagonist mechanisms with Alosetron. This article explores its unique value in dissecting gastrointestinal stem cell fate and polarity, offering researchers a scientifically rigorous perspective beyond standard protocols.
-
lncRNA HITT Attenuates ATM Activation and Sensitizes Cancers
2026-05-03
This study uncovers the long noncoding RNA HITT as a direct regulator of ATM kinase, attenuating its activation and homologous recombination repair in response to DNA double-strand breaks. These findings provide mechanistic insight into how lncRNAs influence DNA damage response and highlight new strategies to sensitize cancer cells to genotoxic therapies.
-
Hepatic sEH Modulates Osteoclastogenesis via Nrf2 in Osteopo
2026-05-02
This study uncovers a novel mechanism by which hepatic soluble epoxide hydrolase (sEH) promotes osteoclast differentiation and bone loss by suppressing the Nrf2 antioxidant pathway, linking liver-derived lipid metabolism to bone homeostasis. The findings reveal the importance of sEH and epoxyeicosatrienoic acid (EET) signaling in osteoporosis, suggesting new experimental avenues for chronic inflammation and bone research.
-
Nigericin Sodium Salt: Ion Transport Protocols and QC Guide
2026-05-01
Nigericin sodium salt is a potassium ionophore used to manipulate ion gradients and cytoplasmic pH in cell-based assays. It is best suited for workflows requiring precise control of K+/H+ exchange, platelet aggregation modulation, and selective Pb2+ ion transport. Its use should be avoided in diagnostic or therapeutic applications due to its research-only designation.
-
10074-G5: Applied c-Myc Inhibition for Cancer Research Workf
2026-05-01
10074-G5 is a benchmark c-Myc inhibitor, unlocking precise modulation of the c-Myc/Max axis for apoptosis, cell cycle arrest, and tumor regression studies. This guide details protocol enhancements, troubleshooting, and advanced applications, bridging recent mechanistic insights with robust experimental design.